Marcelo Antonini

13PUBLICATIONS
59CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersModels of care and place of birthLiquid biopsiesCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 20, 2026
Reoperation rates following breast-conserving surgery in a contemporary cohort.

|Apr 13, 2026
Immune profiling in residual disease: refining risk stratification after neoadjuvant therapy in HER2-positive breast cancer.

Marcelo Antonini, André Mattar, Francisco Pimentel Cavalcante

|Dec 12, 2025
Clinical characteristics and prognostic impact of HER2 low expression in breast cancer subtypes from a Brazilian real-world cohort.

André Mattar, Marcelo Antonini, Francisco Pimentel Cavalcante

|Jul 12, 2025
Is axillary surgery still justified in DCIS diagnosed via vacuum-assisted biopsy?

Marcellus do Nascimento Moreira Ramos, André Mattar, Marcelo Antonini

|Apr 14, 2025
Impact of Shenling Baizhu Powder on lipid profiles and body mass index in breast cancer patients under adjuvant chemotherapy: a retrospective study.

Jiaqing Song, Ying Jin, Qinghong Yu

|Mar 27, 2025
Comparative Analyses of Van Nuys Prognostic Index and NCCN Guidelines in Ductal Carcinoma In Situ Treatment in a Brazilian Hospital.

Marcelo Antonini, Raissa Barros Vasconcelos, André Mattar

Pageof 3

Frequent Collaborators

10 joint publications

Andre Mattar

8 joint publications

Eduardo de Camargo Millen

8 joint publications

Felipe Zerwes

8 joint publications

Francisco Pimentel Cavalcante